ACLX
Price
$75.63
Change
+$0.42 (+0.56%)
Updated
Dec 20, 04:59 PM (EDT)
88 days until earnings call
APGE
Price
$47.67
Change
+$0.65 (+1.38%)
Updated
Dec 20, 04:59 PM (EDT)
79 days until earnings call
Ad is loading...

ACLX vs APGE

Header iconACLX vs APGE Comparison
Open Charts ACLX vs APGEBanner chart's image
Arcellx
Price$75.63
Change+$0.42 (+0.56%)
Volume$4.84K
CapitalizationN/A
Apogee Therapeutics
Price$47.67
Change+$0.65 (+1.38%)
Volume$27.15K
CapitalizationN/A
ACLX vs APGE Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. APGE commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and APGE is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ACLX: $75.54 vs. APGE: $47.71)
Brand notoriety: ACLX and APGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 223% vs. APGE: 126%
Market capitalization -- ACLX: $4.09B vs. APGE: $2.71B
ACLX [@Biotechnology] is valued at $4.09B. APGE’s [@Biotechnology] market capitalization is $2.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileAPGE’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • APGE’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 3 TA indicator(s) are bullish while APGE’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 3 bullish, 6 bearish.
  • APGE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, APGE is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -9.86% price change this week, while APGE (@Biotechnology) price change was +7.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

APGE is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.09B) has a higher market cap than APGE($2.72B). APGE YTD gains are higher at: 70.759 vs. ACLX (36.108). ACLX has higher annual earnings (EBITDA): -33.12M vs. APGE (-169.13M). ACLX has more cash in the bank: 574M vs. APGE (526M). APGE has less debt than ACLX: APGE (12.1M) vs ACLX (65.3M). ACLX has higher revenues than APGE: ACLX (156M) vs APGE (0).
ACLXAPGEACLX / APGE
Capitalization4.09B2.72B151%
EBITDA-33.12M-169.13M20%
Gain YTD36.10870.75951%
P/E RatioN/AN/A-
Revenue156M0-
Total Cash574M526M109%
Total Debt65.3M12.1M540%
TECHNICAL ANALYSIS
Technical Analysis
ACLXAPGE
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 5 days ago
78%
Bullish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 13 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
73%
Aroon
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMDAX4.650.08
+1.75%
Virtus Silvant Mid-Cap Growth A
HMVYX17.980.22
+1.24%
Hartford MidCap Value Y
SENCX71.700.76
+1.07%
Touchstone Large Cap Focused A
CAFAX42.350.42
+1.00%
American Funds AMCAP 529A
MOWNX15.930.06
+0.38%
Moerus Worldwide Value N

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+0.44%
DNLI - ACLX
49%
Loosely correlated
-0.19%
BEAM - ACLX
49%
Loosely correlated
+8.04%
RCKT - ACLX
48%
Loosely correlated
+1.85%
CRSP - ACLX
47%
Loosely correlated
+0.83%
RCUS - ACLX
47%
Loosely correlated
+0.26%
More

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+1.47%
SYRE - APGE
44%
Loosely correlated
+3.16%
BHVN - APGE
43%
Loosely correlated
+2.60%
ACLX - APGE
38%
Loosely correlated
+0.44%
ALLO - APGE
38%
Loosely correlated
+1.63%
IMNM - APGE
35%
Loosely correlated
-0.99%
More